2018
DOI: 10.4103/1673-5374.230299
|View full text |Cite
|
Sign up to set email alerts
|

Induced dural lymphangiogenesis facilities soluble amyloid-beta clearance from brain in a transgenic mouse model of Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(14 citation statements)
references
References 47 publications
0
14
0
Order By: Relevance
“…There has been intense focus on dural lymphatic vessels since their rediscovery in 2015 [144,145,160,162,179,[255][256][257][258][259][260]. Recent studies have found significant changes in CSF clearance, altered pathology in mouse models, or even cognitive defects, after ablation of the dural lymphatic vessels along the superior sagittal or transverse sinuses and it has been hypothesized that these effects are due to the dorsal lymphatic vessels playing a key role in CSF clearance and CNS immunosurveillance [179,255,259].…”
Section: Conclusion and Open Questionsmentioning
confidence: 99%
“…There has been intense focus on dural lymphatic vessels since their rediscovery in 2015 [144,145,160,162,179,[255][256][257][258][259][260]. Recent studies have found significant changes in CSF clearance, altered pathology in mouse models, or even cognitive defects, after ablation of the dural lymphatic vessels along the superior sagittal or transverse sinuses and it has been hypothesized that these effects are due to the dorsal lymphatic vessels playing a key role in CSF clearance and CNS immunosurveillance [179,255,259].…”
Section: Conclusion and Open Questionsmentioning
confidence: 99%
“… 27 While meningeal LV anatomy is better understood, the functional role(s) of meningeal LVs appears to depend on the CNS disease. For example, ablation of meningeal LVs worsens pathology in a mouse model of Alzheimer’s disease, 28 but reduces pathology during experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. 4 As little is known about the formation and function of meningeal LVs during stroke recovery, we investigated the development and relevance of new post-stroke LVs during long-term recovery. We determined that post-stroke meningeal lymphangiogenesis is dependent upon the method of ischemic infarction and does not occur after one the most commonly used preclinical stroke models, tMCAo.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have also tested the effects of boosting the function of the meningeal lymphatics in mouse models of AD. Intracisternal injection of recombinant human VEGF-C promoted dural lymphangiogenesis in 9-month-old APP/PS1 mice, reducing the levels of soluble Aβ 1–40 and Aβ 1–42 in the brain and CSF, and improving cognitive performance ( Wen et al, 2018 ). In a different study, delivery of a viral vector expressing mouse VEGF-C into the cisterna magna of J20 animals at 6–7 months of age did not improve the Aβ levels in the CSF, amyloid deposition in the hippocampus, or cognitive performance ( Da Mesquita et al, 2018b ).…”
Section: Role Of Meningeal Lymphatic (Dys)function In Neurological DImentioning
confidence: 99%
“…These discordant results might be explained by the different degrees of meningeal lymphatic vessel function or by the distinct kinetics of brain Aβ production and plaque development in APP/PS1 and J20 mice ( Mucke et al, 2000 ; Jankowsky et al, 2004 ). The different methods and regimens of VEGF-C delivery employed in each study ( Da Mesquita et al, 2018b ; Wen et al, 2018 ) might also explain the different outcomes. More experimental evidence is needed to better understand if and how VEGF-C treatment can be beneficial to treat AD-associated brain pathology and symptoms.…”
Section: Role Of Meningeal Lymphatic (Dys)function In Neurological DImentioning
confidence: 99%